跳至主要内容
临床试验/IRCT20151227025726N22
IRCT20151227025726N22招募中2 期

Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgery

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients undergoing endarterectomy following chronic thromboembolic pulmonary hypertension at Masih Daneshvari Hospital.

排除标准

  • Any allergies to the prescribed medication
  • Any bleeding includes active gastrointestinal, pulmonary, genitourinary bleeding
  • Cerebral aneurysm
  • Intracranial bleeding
  • Aneurysm and aortic dissection
  • A patient undergoing spinal puncture
  • Blood dyscrasia
  • Uncontrolled blood pressure (110/180 mmHg Inflammation and pericardial effusion
  • Bacterial endocarditis
  • Pregnancy and lactation
  • Liver disease(child pugh B&C)
  • GFR<30 mL/min
  • Any coagulation disorder
  • If the patient has been prescribed strong Cyp450 and Pgp inhibitors such as ketoconazole, itraconazole, posaconazole and ritonavir.

研究者

相似试验